Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

NCT05572983 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Interventions

DRUG: Chidamide combined with CHOP
DRUG: Chidamide

Sponsor

Sun Yat-sen University